Results 1 to 10 of about 2,054,122 (239)

Transcatheter Tricuspid Valve Therapy: From Anatomy to Intervention [PDF]

Frontiers in Cardiovascular Medicine, 2021
Nowadays, severe symptomatic tricuspid regurgitation (TR) affects millions of persons worldwide. However, the benefit of surgical correction of isolated secondary TR remains controversial because of the increased risk of periprocedural mortality and ...
Valeria Cammalleri, Myriam Carpenito, Maria Caterina Bono, Simona Mega, Gian Paolo Ussia, Francesco Grigioni   +5 more
doaj   +9 more sources

Unsolved questions in prophylactic tricuspid valve repair and the possible role of transcatheter tricuspid intervention. [PDF]

Am J Cardiovasc Dis, 2020
Tricuspid regurgitation progression after left-sided surgery and its correlation with worse postoperative and long-term outcomes is a highly debated topic.
Tagliari AP, Santos DV, Saadi EK, Taramasso M, Mestres CA.   +4 more
europepmc   +5 more sources

Transcatheter Tricuspid Valve Intervention: Coaptation Devices [PDF]

Frontiers in Cardiovascular Medicine, 2020
Transcatheter tricuspid valve intervention (TTVI) has recently emerged as an alternative for the treatment of severe tricuspid regurgitation (TR). Multiple percutaneous devices have been developed in the last decade with promising early results.
Guillem Muntané-Carol, Alberto Alperi, Laurent Faroux, Elisabeth Bédard, François Philippon, Josep Rodés-Cabau   +5 more
doaj   +5 more sources

Sex-Related Differences in Clinical Characteristics and Outcome Prediction Among Patients Undergoing Transcatheter Tricuspid Valve Intervention [PDF]

JACC: Cardiovascular Interventions, 2023
BACKGROUND Men and women differ regarding comorbidities, pathophysiology, and the progression of valvular heart diseases. OBJECTIVES This study sought to assess sex-related differences regarding clinical characteristics and the outcome of patients with
Volker Rudolph, Tanja Rudolph, Roman Pfister   +2 more
exaly   +3 more sources

Simplified Outcome Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention by Survival Tree-Based Modelling

JACC: Advances
Background: Patients with severe tricuspid regurgitation (TR) typically present with heterogeneity in the extent of cardiac dysfunction and extra-cardiac comorbidities, which play a decisive role for survival after transcatheter tricuspid valve ...
Vera Fortmeier, MD, Mark Lachmann, MD, Lukas Stolz, MD, Jennifer von Stein, MD, Karl-Philipp Rommel, MD, Mohammad Kassar, MD, Muhammed Gerçek, MD, Anne R. Schöber, MD, Thomas J. Stocker, MD, Hazem Omran, MD, Michelle Fett, Jule Tervooren, Maria I. Körber, MD, Amelie Hesse, Gerhard Harmsen, PhD, Kai Peter Friedrichs, MD, Shinsuke Yuasa, MD, PhD, Tanja K. Rudolph, MD, Michael Joner, MD, Roman Pfister, MD, Stephan Baldus, MD, Karl-Ludwig Laugwitz, MD, Stephan Windecker, MD, Fabien Praz, MD, Philipp Lurz, MD, Jörg Hausleiter, MD, Volker Rudolph, MD   +26 more
doaj   +4 more sources

Integrating Biomarkers and Hemodynamics for 1-Year Mortality Risk Stratification in Transcatheter Tricuspid Intervention. [PDF]

CJC Open
Background Transcatheter tricuspid interventions for severe tricuspid regurgitation are being used increasingly, yet many patients present at an advanced stage, when clinical benefit is limited.
Edlinger C, Schlegl J, Bannehr M, Lichtenauer M, Kücken T, Krutz A, Paar V, Neuß M, Haase-Fielitz A, Butter C.   +9 more
europepmc   +2 more sources

Patient Selection for Transcatheter Tricuspid Valve Intervention: Not Too Early, Not Too Late

Structural Heart
Tricuspid regurgitation (TR) is a common but frequently underrecognized condition associated with substantial morbidity and mortality. Long regarded as a mere bystander of left-sided heart disease, TR was often left untreated, contributing to late ...
Jennifer von Stein, MD, Philipp von Stein, MD, Maria C. Alu, MS, Andrea Scotti, MD, Edwin C. Ho, MD, Juan F. Granada, MD, Azeem Latib, MD   +6 more
doaj   +2 more sources

“Guidelines Recommendations on the Treatment of Tricuspid Regurgitation. Where Are We and Where Do We Go With Transcatheter Valve Intervention”

Frontiers in Cardiovascular Medicine, 2018
Tricuspid regurgitation (TR) is an important clinical problem because it is frequent and carries a poor prognosis when it is left uncorrected. However, there is still a lack of awareness of tricuspid disease in the medical community.
Alec Vahanian, Eric Brochet, Jean-Michel Juliard   +2 more
doaj   +3 more sources

Clinical and Echocardiographic Outcomes of Transcatheter Tricuspid Valve Interventions: A Systematic Review and Meta-Analysis

Frontiers in Cardiovascular Medicine, 2022
BackgroundMedically managed tricuspid regurgitation (TR) has detrimental outcomes. Transcatheter tricuspid valve interventions (TTVIs) represent an alternative to surgery in high-risk patients; however, only early experiences exist.AimThe aim of this ...
Anna Sannino, Anna Sannino, Federica Ilardi, Federica Ilardi, Rebecca T. Hahn, Patrizio Lancellotti, Patrizio Lancellotti, Philipp Lurz, Robert L. Smith, Giovanni Esposito, Paul A. Grayburn   +10 more
doaj   +3 more sources

Expanding the Tools for Transcatheter Tricuspid Valve Intervention

JACC: Case Reports, 2020
Maurizio Taramasso, MD, PhD
doaj   +3 more sources